, Pentadecapeptide BPC 157 and the central nervous system, Medknow, 2022
All consultations, follow-ups, and medication management occur securely through telehealth without any in-person visits
Patients on insulin or oral diabetes medications may need monitoring or dose adjustments
21 Imatinib has also been linked to Stevens-Johnson syndrome, acute generalized exanthematous pustulosis, and Sweet syndrome (acute febrile neutrophilic dermatosis)
Key weight loss results at 48 weeks by group: Response rates at 48 weeks (12 mg dose): 100% achieved greater than or equal to 5% weight loss 93% achieved greater than or equal to 10% weight loss 83% achieved greater than or equal to 15% weight loss The cardiometabolic improvements were also significant, with reductions in blood pressure, triglycerides, LDL cholesterol, HbA1c, fasting glucose, and fasting insulin across all dose groups
e , Representative epifluorescence images of SiR-Hoechst- and SYTOX-labeled U-2 OS cells treated with the indicated siRNAs